Continuity Biosciences, LLC

United States · Biotechnology Research

The difference between a promising therapy and a transformative one often comes down to delivery. Continuity Biosciences builds precision delivery platforms that close the gap between what a therapy can do and what a patient actually experiences. Our adaptive, therapy-agnostic technologies support applications across oncology, chronic disease, and medical aesthetics, spanning small molecules, biologics, and cell-based therapies. We don't build around a single drug or indication. We build infrastructure for better therapeutic delivery, wherever it matters most. Our science is rooted in research from Houston Methodist, University of Miami, University of North Carolina. Our collective work spans 135 publications and 80 patents—not as a measure of the past, but as a foundation for what comes next. We welcome conversations with partners, investors, and collaborators. Reach out or follow along as we build.